|
||||||||||||||||
| HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
| Cardiovascular Disease Drug Discovery & Development Summit | ||||||||||||||||
| October 16, 2002 | ||||||||||||||||
|
Strategic Research Institute, Coronado Island Marriott Resort, San Diego, CA Feb 10-11th , 2003 *Translation of Genomic Findings into Cardiovascular Therapeutics *Cytochrome P450 Inhibitors Attenuate Cardiac Ischemia and Repurfusion Injury *Role of A2B Adenosine Receptor in Angiogenesis * Targeting VEGF Receptors for Angiogenesis Therapies * In Vivo Dissection of PDGF Receptor Signaling Pathways in VSMC |
||||||||||||||||
| Organized by: | Jon Liong | |||||||||||||||
| Invited Speakers: | Ali Raza, M.D., Global Team Leader ASTRAZENECA Chih-Hao Lee, Associate Director SALK INSTITUTE Rosanne M. Crooke Ph.D., Program Leader, Cardiovascular Diseases ISIS PHARMACEUTICALS |
|||||||||||||||
| Deadline for Abstracts: | tbd | |||||||||||||||
| Registration: | 888-666-8514 | |||||||||||||||
| E-mail: | jliong@srinstitute.com | |||||||||||||||
| Posted by: | Jennifer Law | |||||||||||||||
| Host: | 12.3.58.15 | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||